Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project

Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients

(2011) Edward J. Mills et al.   EUROPEAN HEART JOURNAL

Statins for Secondary Prevention of Cardiovascular Disease: The Right Dose

(2011) Reynold Spector et al.   PHARMACOLOGY

PCV67 COST AND OUTCOMES AFTER FIRST ACUTE MYOCARDIAL INFARCTION: STUDY ON 12049 INDIVIDUALS USING ADMINISTRATIVE DATABASES

(2011) LG Mantovani et al.   VALUE IN HEALTH

Risk of All-Cause Mortality, Recurrent Myocardial Infarction, and Heart Failure Hospitalization Associated With Smoking Status Following Myocardial Infarction With Left Ventricular Dysfunction

(2010) Amil M. Shah et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of Smoking on Cardiovascular Events in Patients With Coronary Disease Receiving Contemporary Medical Therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] Trials)

(2010) Paul Frey et al.   AMERICAN JOURNAL OF CARDIOLOGY

The dynamics of mortality in follow-up time after an acute myocardial infarction, lower extremity arterial disease and ischemic stroke

(2010) Ilonca Vaartjes et al.   BMC Cardiovascular Disorders

Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials

(2010) E. J. Mills et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Population-based health-economic evaluation of the secondary prevention of coronary heart disease in Finland

(2009) Erkki J.O. Soini et al.   CURRENT MEDICAL RESEARCH AND OPINION

Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry

(2009) M. J. Alberts et al.   EUROPEAN HEART JOURNAL

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

(2009) Kornelia Kotseva et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

A systematic review and meta-analysis on the therapeutic equivalence of statins

(2009) T.-C. Weng et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model

(2009) Björn Schwander et al.   VALUE IN HEALTH

Cost-Effectiveness of Clopidogrel plus Aspirin versus Aspirin Alone for Secondary Prevention of Cardiovascular Events: Results from the CHARISMA Trial

(2009) Jersey Chen et al.   VALUE IN HEALTH

Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population

(2008) Ginés Sanz et al.   Nature clinical practice. Cardiovascular medicine